Quantcast
Last updated on April 24, 2014 at 6:43 EDT

Latest pharmaceutical industry Stories

2014-04-01 23:03:33

An increase in R&D spending for new technologies will stimulate growth. For this reason, industry research firm IBISWorld has added a report on the Animal Health Biotechnology industry to its growing industry report collection. New York, NY (PRWEB) April 01, 2014 The Animal Health Biotechnology industry is heavily dependent on external funding to drive the technologically sophisticated research that produces new animal healthcare products and services. As such, revenue contracted in...

2014-04-01 23:03:13

Clinical Trial Magnifier Weekly monitors 150,000 trials in 185 countries around the world every week and reports all the fresh changes. Subscribers are able to scan all the changes and drill down using links in the newsletter to focus on the ones that are important, saving them countless hours of effort. Falls Church, VA (PRWEB) April 01, 2014 Clinical Trial Magnifier Weekly http://www.fdanews.com/CTM FDAnews is proud to announce the release of Clinical Trial Magnifier Weekly. Clinical...

2014-04-01 14:31:40

OHSU analysis in Annals of Internal Medicine finds journals reported adverse events less frequently Medical researchers often presented the findings of their clinical trials in a different way on a federal government website than they did in the medical journals where their studies were ultimately published, according to an Oregon Health & Science University analysis published April 1 in the Annals of Internal Medicine. Researchers' reports in peer-reviewed medical journals often...

2014-04-01 12:33:44

LONDON, April 1, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Alzheimer's Pipeline Drugs Review, Alzheimer's Disease Drug Market & Forecast - Global Analysis Alzheimer's disease drug market is on the curvature stage. Since 2003, there is not any single "magic bullet" launched in the market to prevent or cure it. However, all current marketed products are going to be generic in the next 3-4 years. There are high unmet medical needs....

2014-04-01 08:30:29

Webinar to Explore Cutting-Edge Use of Data Analytics that Challenges Traditional Approach to Feasibility Studies and Significantly Increases Predictability BURLINGTON, Mass., April 1, 2014 /PRNewswire/ -- inVentiv Clinical Trial Recruitment Solutions (iCTRS), created to accelerate trials efficiently and predictably, will discuss the latest innovations in trial feasibility during a webinar next week hosted by Clinical Informatics News. Otis Johnson, executive director of...

2014-04-01 08:29:43

Raleigh Convention Center on April 8th RALEIGH, N.C., April 1, 2014 /PRNewswire/ -- An expected 1000 life science professionals from Pfizer, Biogen Idec, Novartis, GlaxoSmithKline, Novo Nordisk, Grifols, and many others will gather at the ISPE-CaSA Life Sciences Technology Conference, Tuesday, April 8, 2014, 10:00 am-7:00 pm (http://ispe-casa.org/2014/) on the top floor of the Raleigh Convention Center, 500 S. Salisbury St., Raleigh, NC, to learn the latest manufacturing techniques through...

2014-04-01 08:29:34

- Establishes Leading Position in Fast-Growing Thai Pharmaceutical Market - DUBLIN, April 1, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company today announced that it has acquired Silom Medical Company, a privately held generic pharmaceutical company focused on developing and marketing therapies in Thailand, for approximately $100 million in cash. The acquisition of Silom Medical immediately elevates Actavis into a top-five position...

2014-04-01 08:29:32

WOODCLIFF LAKE, N.J., April 1, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that Terrance J. Coughlin has been named chief operating officer. In this capacity, Mr. Coughlin will be responsible for Par's global manufacturing activities, research and development efforts and will be instrumental in the new product selection process. Mr. Coughlin joins Par from Glenmark Generics, Inc. USA/Glenmark Generics Limited where he most recently served as president...

2014-04-01 08:28:55

ROCKLAND, Mass., April 1, 2014 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, today announced the launch of the 10(th) edition of the EMD Serono Specialty Digest(TM) at the 26(th) Annual Meeting of The Academy of Managed Care Pharmacy (AMCP) in Tampa, FL. The Digest is an educational resource that provides market data on health plans' management of specialty pharmaceuticals in 2013 and identifies common trends occurring across plans. The Digest is...

2014-04-01 08:28:47

DUBLIN, April 1, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has successfully completed the divestiture of its generics commercial operations in seven markets in Western Europe to Aurobindo Pharma Limited (BSE: 524804). The agreement to divest the commercial operations was announced in January 2014. http://photos.prnewswire.com/prnvar/20130124/NY47381LOGO Aurobindo acquired Actavis' pharmaceutical commercial infrastructure in France, Italy, Spain,...